Investment in Equity Securities - Additional Information (Details)		12 Months Ended
	Dec. 31, 2022	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Schedule of Equity Method Investments [Line Items]
Payments to acquire equity securities without readily determinable fair value		$ 0	$ 4,700,000
Equity securities without readily determinable fair Value, impairment loss, annual amount		$ 2,990,000	0
Measurement Input Probability [Member] | Valuation Dynamic Options Approach [Member]
Schedule of Equity Method Investments [Line Items]
Equity securities without readily determinable fair value, measurement input		0.50
Measurement Input Probability [Member] | Valuation, Cost Approach [Member]
Schedule of Equity Method Investments [Line Items]
Equity securities without readily determinable fair value, measurement input		0.50
Measurement Input, Expected Term [Member]
Schedule of Equity Method Investments [Line Items]
Equity securities without readily determinable fair value, measurement input		3.5
Dynamic Cell Therapies, Inc. [Member]
Schedule of Equity Method Investments [Line Items]
Payments to acquire equity securities without readily determinable fair value			$ 4,700,000
Variable interest entity, qualitative or quantitative information, ownership percentage	19.00%